GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ELAN · Sep 30, 2024

Elanco Animal Health Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001739104-24-000039General Corporate
Debt relative to revenue40thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.debt_to_revenue

423.01% · OPTIONAL · VALID

Capex intensity79thOwn-history percentile · N=19
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

4.08% · OPTIONAL · VALID

Operating cash generation75thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

15.73% · OPTIONAL · VALID

Revenue growth35thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

-3.56% · CORE · VALID

Inventory pressure85thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

158.45% · OPTIONAL · VALID

Gross margin25thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

52.23% · CORE · VALID

R&D intensity70thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

8.45% · OPTIONAL · VALID

SBC intensity75thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.46% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
479.39%
Current
423.01%
Delta
-56.38%
Capex Intensity Increased
Previous
2.87%
Current
4.08%
Delta
1.21%
Cash Generation Decreased
Previous
16.89%
Current
15.73%
Delta
-1.16%
Growth Decreased
Previous
12.02%
Current
-3.56%
Delta
-15.57%
Inventory Pressure Increased
Previous
136.06%
Current
158.45%
Delta
22.38%
Margin Decreased
Previous
58.19%
Current
52.23%
Delta
-5.96%
R And D Intensity Increased
Previous
7.52%
Current
8.45%
Delta
0.93%
Sbc Intensity Increased
Previous
1.18%
Current
1.46%
Delta
0.27%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ELAN Fundamental State →Has State · Elanco Animal Health Inc →Transitioned To · ELAN CAPEX_INTENSITY_INCREASED →Transitioned To · ELAN CASH_GENERATION_DECREASED →Transitioned To · ELAN GROWTH_DECREASED →Transitioned To · ELAN INVENTORY_PRESSURE_INCREASED →Transitioned To · ELAN MARGIN_DECREASED →Transitioned To · ELAN R_AND_D_INTENSITY_INCREASED →Transitioned To · ELAN SBC_INTENSITY_INCREASED →Transitioned To · ELAN Fundamental State →Transitioned To · ELAN BALANCE_SHEET_LEVERAGE_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.